| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4aba5130b481ea5be1710d495eac3cad |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6527
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0489
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65583
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6524
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-2458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B59-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6524
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6527 |
| filingDate |
2016-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd99088142447d2cfcbc19dae010d7fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d42ff08ebb9aafc48a00d34a7d17af75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f9d6aea5aac9b9d4af57cc5f17c2327 |
| publicationDate |
2018-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9974869-B2 |
| titleOfInvention |
Chelated PSMA inhibitors |
| abstract |
Compounds as defined herein are provided which are useful in (1) diagnostic methods for detecting and/or identifying cells presenting PSMA; (2) compositions comprising a compound of the invention together with a pharmaceutically acceptable diluent; and (3) methods for imaging prostate cancer cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11554183-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016030605-A1 |
| priorityDate |
2011-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |